2022-500508-23-00招募中1 期
Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 116
- 试验地点
- 17
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Global Regulatory Affairs
Scientific
Merck Healthcare KGaA
研究点 (17)
Loading locations...
相似试验
招募中
1 期
A Phase 1 Study of HDM2017 in Advanced Solid TumorsSolid TumorsNCT07274085Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.96
招募中
1 期
BTM-3566 in Advanced Solid TumorsAdvanced Solid TumorsNCT07266285Bantam Pharmaceuticals30
招募中
1 期
A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)Lung Neoplasm MalignantNCT07286149Merck Sharp & Dohme LLC140
尚未招募
2 期
PRaG-1 Plus PRaG Therapy in Advanced Solid Tumors: A Prospective Clinical Trial (PRaG 10.0)Solid CancerRadiotherapyImmune Checkpoint InhibitorLymphopeniaNCT07267234Second Affiliated Hospital of Soochow University65
招募中
1 期
VSV-02 Compassionate Use in Advanced Solid TumorsMelanomaAdvanced Solid TumorImmunotherapyCancer TreatmentBreast CancerLung CancerNCT07260591The First Affiliated Hospital of Xinxiang Medical College6